Vertex Pharmaceuticals | VRTX - 应收帐款人



金融业
股票价格
USD 508.99
资产
USD 27.42B
现金及等价物
USD 7.85B
销售成本
USD 489.2M
流动资产
USD 12.54B
流动负债
USD 3.94B
债务
USD 1.98B
EBIT
USD 1.27B
EBITDA
USD 1.33B
员工
6.1K
EPS每股收益
USD 4.73
股本和储备
USD 20.25B
销售毛利
USD 2.84B
债务利息支出
USD 3.3M
利息收入
USD 120.6M
贷款资金
USD 106.7M
市值
USD 131.68B
净收入
USD 1.1B
营业费用
USD 2.07B
营业利润
USD 1.27B
普通股股本
USD 253.3M
PE价格收益
28.05
税前利润
USD 1.39B
销售收入
USD 3.33B
销售和管理费用
USD 582.2M
股票
USD 1.77B
贸易债权人
USD 3.61B
应收帐款人
USD 2.13B


应收帐款人 更改 日
AbbVie USD 12.48B 110M 2026-03
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amgen USD 10.23B 1.09B 2026-06
Arrowhead Research USD 8.56M 7.13M 2026-06
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Gilead Sciences USD 5.06B 314M 2026-06
Incyte USD 1.13B 73.7M 2026-06
Insmed USD 215.32M 36.77M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
J&J USD 19.05B 3.49B 2026-06
Merck USD 12.21B 435M 2026-03
Moderna USD 17M 54M 2026-06
Neurocrine Biosciences USD 887M 118.9M 2026-06
Novartis USD 9.85B 252M 2026-06
Pfizer USD 16.19B 19M 2026-06
PTC Therapeutics USD 219.92M 38.3M 2026-03
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 492M 10M 2026-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
United Therapeutics USD 310.3M 1.7M 2026-06
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06